Montreal Heart Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2015

  1. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    PLoS ONE, Vol. 10, Núm. 4

2010

  1. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study

    Archives of Cardiovascular Diseases, Vol. 103, Núm. 3, pp. 160-169

2008

  1. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design

    Archives of Cardiovascular Diseases, Vol. 101, Núm. 6, pp. 399-406

1992

  1. Favorable effects of hyperosmotic reperfusion on myocardial edema and infarct size

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 262, Núm. 1 31-1

  2. Selective inhibition of the contractile apparatus: A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion

    Circulation, Vol. 85, Núm. 3, pp. 1160-1174

1991

  1. Role of oxygen restoration in reperfusion-induced arrhythmias: Differential effects on ventricular ectopic activity and ventricular fibrillation in the pig

    Journal of Applied Cardiology, Vol. 6, Núm. 6, pp. 411-420

1990

  1. Determinants of hemorrhagic infarcts: Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion

    American Journal of Pathology, Vol. 137, Núm. 2, pp. 301-311

  2. Intracoronary infusion of superoxide dismutase and reperfusion injury in the pig heart

    Basic Research in Cardiology, Vol. 85, Núm. 6, pp. 619-629

1988

  1. Influence of tachycardia and arterial hypertension on infarct size in the pig

    Cardiovascular Research, Vol. 22, Núm. 9, pp. 620-626